As 2017 draws to a close, we look back at a year where advances in pharmaceutical drug therapies brought new hope to people from across the globe. These steps forward bring with them a sense of suspense as we wait for more ground-breaking work to be accomplished in 2018. Here is Drugdu.com’s list of medical advances that amazed.
A new drug developed by Merck & Co and Pfizer Inc won U.S. approval on Wednesday to treat type II diabetes, the Food and Drug Administration(FDA) said, adding another competitor to a growing class of treatments.
If left unidentified, a compulsive behavior can turn into a new addiction. Even if your substance recovery is strong, you can’t ignore the fact that other addictions can come forward.
Heart disease kills more than 360,000 people a year, in the US alone. During a heart attack, a person loses blood flow to the heart muscle, causing cells to die. The heart muscle cells can't be replaced, so the body forms scar tissue, which puts the person at risk for compromised heart function and future heart failure.
Most of us have had a broken bone at some point in our lives and we can all agree that it is not a pleasant feeling. Our skeletal system, though not fragile, is susceptible to an occasional crack or a full-blown broken bone.
Researchers from the University of Bern, Inselspital, Bern University Hospital and the Swiss Center for Electronics and Microtechnology develop a high-precision, sensor-based surgical robot for spinal operations together with industry partners. Their project is being funded with two million Swiss francs, sponsored by the "BRIDGE" programme of the Swiss National Science Foundation and the Commission for Technology and Innovation.
Roche’s Alecesna has been cleared for use in Europe as a first-line treatment for ALK-positive non-small cell lung cancer (NSCLC), offering a new option for patients newly diagnosed with the disease.
Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors, announced the completion of a USD 80 million financing round led by Temasek, an investment company headquartered in Singapore, and joined by EDBI, Karst Peak Capital, Heliconia, Heritas and other investors.
Background Being unmarried is associated with decreased survival in the general population. Whether married, divorced, separated, widowed, or never‐married status affects outcomes in patients with cardiovascular disease has not been well characterized.
There's no shortage of info (and misinformation) out there about when to get pregnant - or when not to. But no matter what your search engine, great aunt, or the random lady standing next to you in line for coffee says, there's no magical right time. However, there are plenty of factors that may offer a sneak peek into the type of pregnancy you'll have. How old you are? Yep, that's definitely one of them.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.